721 related articles for article (PubMed ID: 34535527)
1. Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.
Terlizzi K; Kutscher E; Yoncheva Y
J Am Board Fam Med; 2021; 34(5):1014-1016. PubMed ID: 34535527
[TBL] [Abstract][Full Text] [Related]
2. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
[TBL] [Abstract][Full Text] [Related]
3. The other COVID-19 survivors: Timing, duration, and health impact of post-acute sequelae of SARS-CoV-2 infection.
Lambert N; ; El-Azab SA; Ramrakhiani NS; Barisano A; Yu L; Taylor K; Esperança Á; Mendiola C; Downs CA; Abrahim HL; Hughes T; Rahmani AM; Borelli JL; Chakraborty R; Pinto MD
J Clin Nurs; 2024 Jan; 33(1):76-88. PubMed ID: 36181315
[TBL] [Abstract][Full Text] [Related]
4. Long COVID outcomes following omicron wave in non-hospital population.
Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
[TBL] [Abstract][Full Text] [Related]
5. Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition.
Wander PL; Baraff A; Fox A; Cho K; Maripuri M; Honerlaw JP; Ho YL; Dey AT; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Viglianti E; Iwashyna TJ; Hynes DM; Osborne TF; Ioannou GN
JAMA Netw Open; 2023 Dec; 6(12):e2346783. PubMed ID: 38064215
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
8. Before and after COVID-19: Changes in symptoms and diagnoses in 13,033 adults.
Butler MJ; Chiuzan C; Ahn H; Gao M; D'Angelo S; Yeh J; Davidson K
PLoS One; 2024; 19(3):e0286371. PubMed ID: 38457409
[TBL] [Abstract][Full Text] [Related]
9. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
Nasserie T; Hittle M; Goodman SN
JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
[TBL] [Abstract][Full Text] [Related]
11. Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydah S; Block JP;
BMC Infect Dis; 2024 Feb; 24(1):181. PubMed ID: 38341566
[TBL] [Abstract][Full Text] [Related]
12. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
[TBL] [Abstract][Full Text] [Related]
13. Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series.
Shoucri SM; Purpura L; DeLaurentis C; Adan MA; Theodore DA; Irace AL; Robbins-Juarez SY; Khedagi AM; Letchford D; Harb AA; Zerihun LM; Lee KE; Gambina K; Lauring MC; Chen N; Sperring CP; Mehta SS; Myers EL; Shih H; Argenziano MG; Bruce SL; Slater CL; Tiao JR; Natarajan K; Hripcsak G; Chen R; Yin MT; Sobieszczyk ME; Castor D; Zucker JE
BMJ Open; 2021 Jun; 11(6):e049488. PubMed ID: 34083350
[TBL] [Abstract][Full Text] [Related]
14. Persistent CD8
LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
[TBL] [Abstract][Full Text] [Related]
15. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
[TBL] [Abstract][Full Text] [Related]
16. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors.
Brunner-Ziegler S; Bäuerle M; Brühl P; Kornek G; Parschalk B; Savic R; Schnetzinger M; Spath T; Straßl RP; Handisurya A; Thalhammer F
J Infect Public Health; 2023 Apr; 16(4):596-602. PubMed ID: 36842195
[TBL] [Abstract][Full Text] [Related]
17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
18. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring the development of post-COVID–19 syndrome].
Tamasi J; Kalabay L
Orv Hetil; 2022 Feb; 163(9):335-342. PubMed ID: 35220274
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
